Clinical Trials
3 trialsNCT04532372 2024-07-03
Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy
City of Hope Medical Center
Phase 1/2 Completed
NCT02509052 2023-10-10
Leflunomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
City of Hope Medical Center
Phase 1/2 Completed
NCT03449758 2022-04-28
SariPRO
Sanofi
Phase 4 Completed